Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000188920 | SCV000242550 | pathogenic | not provided | 2012-09-07 | criteria provided, single submitter | clinical testing | p.Gln1203Stop (CAA>TAA):c.3607 C>T in exon 18 of the SCN1A gene (NM_001165963.1) The Gln1203Stop nonsense mutation in the SCN1A gene is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is found in EPILEPSY panel(s). |
Labcorp Genetics |
RCV001852495 | SCV002235205 | pathogenic | Early infantile epileptic encephalopathy with suppression bursts | 2021-02-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln1203*) in the SCN1A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SCN1A are known to be pathogenic (PMID: 17347258, 18930999). This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with epilepsy and/or neurodevelopmental disorder (PMID: 29655203). ClinVar contains an entry for this variant (Variation ID: 206803). For these reasons, this variant has been classified as Pathogenic. |